Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study

NCT ID: NCT01465620

Last Updated: 2018-08-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

8 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-11-30

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Metabolic disorders such as diabetes mellitus, glucose intolerance and possibly metabolic syndrome can induce a peripheral neuropathy. To investigate the effect of physical training and diet education on neuropathic symptoms and neurophysiological parameters of patients with metabolic neuropathies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Metabolic disorder such as diabetes mellitus, glucose intolerance and possibly metabolic syndrome can induce a peripheral neuropathy. The objectives of the present study are to investigate:

1. the effect of physical training and diet education on neuropathic symptoms and neurophysiological parameters
2. the best coaching modality of education.

This will be a prospective single blind study (blinded evaluator). Patients will be randomly assigned in two groups. The first group will have a one-day therapeutic education program followed by a 5-minutes phone call every week for 3 months. The second group will have the same one-day therapeutic education program that will be followed by an unique one-hour phone call. During the one-day therapeutic education program and the phone calls, hygienic rules (ie physical activities) and dietetic regimen advices will be given to patients. Evaluation will be done at 3 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peripheral Nervous System Diseases Diabetic Polyneuropathy Metabolic Syndrome X

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Coaching

active hygienic-dietetic coaching

Group Type EXPERIMENTAL

hygienic-dietetic measures

Intervention Type BEHAVIORAL

Therapeutic education about hygienic-dietetic measures followed by a 5 minutes phone call per week during 3 months

control

reference hygienic-dietetic recommendations

Group Type ACTIVE_COMPARATOR

hygienic-dietetic measures

Intervention Type BEHAVIORAL

Therapeutic education about hygienic-dietetic measures followed by only one phone call

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

hygienic-dietetic measures

Therapeutic education about hygienic-dietetic measures followed by a 5 minutes phone call per week during 3 months

Intervention Type BEHAVIORAL

hygienic-dietetic measures

Therapeutic education about hygienic-dietetic measures followed by only one phone call

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical and neurophysiologic neuropathy (clinical signs of neuropathy and at least two low sensory nerve action potential (superficial peroneal and sural nerves))
* Metabolic disorder: Glucose disorder (diabetes mellitus or glucose intolerance) or metabolic syndrome
* Clinical signs for less than 2 years
* No therapeutic modification in the last 3 months
* Possibility to delay any drug modification during 3 months

Exclusion Criteria

* Non metabolic neuropathy
* Serious diabetic complication
* Renal failure (creatinine clearance\<60ml/min)
* Sensory neuronopathy
* Contra-indication to physical activity
* Type 1 diabetes mellitus
* No written consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Henri Mondor University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sophie Ng Wing Tin

Investigator, clinical doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alain Créange, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Henri Mondor University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Henri Mondor

Créteil, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HM01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pain In Neuropathy Study
NCT02672059 UNKNOWN